1.2400
27-November-24 15:45:00
15 minutes delayed
Stocks
+0.1300
+11.71%
Today's range
1.1300 - 1.3600
ISIN
N/A
Source
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 Jan 2021 06:00:00 By Nasdaq GlobeNewswire